These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors. Rubinger M; Houston DS; Schwetz N; Woloschuk DM; Israels SJ; Johnston JB Am J Hematol; 1997 Oct; 56(2):112-8. PubMed ID: 9326353 [TBL] [Abstract][Full Text] [Related]
8. Further evidence that the residual vWf:Ag in porcine FVIII:C induces human platelet aggregation. Saniabadi AR; Marney Y; Belch JJ; Lowe GD; Barbenel JC; Madhok R; Forbes CD Haemostasis; 1990; 20(5):289-95. PubMed ID: 2127038 [TBL] [Abstract][Full Text] [Related]
9. Recombinant B-domain-deleted porcine sequence factor VIII (r-pFVIII) for the treatment of bleeding in patients with congenital haemophilia A and inhibitors. Mahlangu JN; Andreeva TA; Macfarlane DE; Walsh C; Key NS Haemophilia; 2017 Jan; 23(1):33-41. PubMed ID: 27761964 [TBL] [Abstract][Full Text] [Related]
10. Thrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia. Ashrani AA; Reding MT; Greeno EW; Shet A; Key NS Haemophilia; 2002 Jan; 8(1):56-8. PubMed ID: 11886466 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A. Kempton CL; Abshire TC; Deveras RA; Hoots WK; Gill JC; Kessler CM; Key NS; Konkle BA; Kuriakose P; Macfarlane DE; Bergman G Haemophilia; 2012 Sep; 18(5):798-804. PubMed ID: 22512291 [TBL] [Abstract][Full Text] [Related]
12. Investigation of porcine parvovirus among persons with hemophilia receiving Hyate:C porcine factor VIII concentrate. Soucie JM; Erdman DD; Evatt BL; Anderson LJ; Török TJ; El-Jamil M; Barnhart E; Tepper M; Burrill HN; Pickett AM; Mengeling WL Transfusion; 2000 Jun; 40(6):708-11. PubMed ID: 10864993 [TBL] [Abstract][Full Text] [Related]
13. Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international survey. Hay CR; Lozier JN; Lee CA; Laffan M; Tradati F; Santagostino E; Ciavarella N; Schiavoni M; Fukui H; Yoshioka A; Teitel J; Mannucci PM; Kasper CK Thromb Haemost; 1996 Jan; 75(1):25-9. PubMed ID: 8713775 [TBL] [Abstract][Full Text] [Related]
14. Recombinant porcine factor VIII for high-risk surgery in paediatric congenital haemophilia A with high-titre inhibitor. Croteau SE; Abajas YL; Wolberg AS; Nielsen BI; Marx GR; Baird CW; Neufeld EJ; Monahan PE Haemophilia; 2017 Mar; 23(2):e93-e98. PubMed ID: 28124406 [TBL] [Abstract][Full Text] [Related]
16. Management of spontaneous inhibitors in children with porcine factor VIII. Kobrinsky NL; Stegman D; Sjolander D Haemophilia; 2002 Jan; 8 Suppl 1():1-4; discussion 28-32. PubMed ID: 11882074 [TBL] [Abstract][Full Text] [Related]
17. Review of recombinant anti-haemophilic porcine sequence factor VIII in adults with acquired haemophilia A. Fosbury E; Drebes A; Riddell A; Chowdary P Ther Adv Hematol; 2017 Sep; 8(9):263-272. PubMed ID: 29051804 [TBL] [Abstract][Full Text] [Related]
18. Platelet-delivered factor VIII provides limited resistance to anti-factor VIII inhibitors. Gewirtz J; Thornton MA; Rauova L; Poncz M J Thromb Haemost; 2008 Jul; 6(7):1160-6. PubMed ID: 18433455 [TBL] [Abstract][Full Text] [Related]
19. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience. Brettler DB; Forsberg AD; Levine PH; Aledort LM; Hilgartner MW; Kasper CK; Lusher JM; McMillan C; Roberts H Arch Intern Med; 1989 Jun; 149(6):1381-5. PubMed ID: 2499293 [TBL] [Abstract][Full Text] [Related]